Skip to main content
logo
Orum Therapeutics, Inc. (KOSDAQ:475830)
South Korea flag South Korea · Delayed Price · Currency is KRW
59,200
-5,800 (-8.92%)
Sep 1, 2026, 3:30 PM KST

Orum Therapeutics Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
1,285,8002,547,884---
Market Cap Growth
137.46%----
Enterprise Value
1,130,0912,429,338---
Last Close Price
59200.00120000.00---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
31706.51108125.08---
PB Ratio
6.9119.47---
P/TBV Ratio
6.9119.47---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
EV/Sales Ratio
-103094.30---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.520.200.230.200.24
Debt / EBITDA Ratio
---0.27-
Debt / FCF Ratio
---0.28-
Net Debt / Equity Ratio
-0.84-0.82-0.74-0.78-0.89
Net Debt / EBITDA Ratio
2.502.2116.55-1.030.22
Net Debt / FCF Ratio
2.952.927.21-1.080.23
Asset Turnover
000.131.48-
Quick Ratio
3.098.523.8113.921.36
Current Ratio
3.138.613.8513.951.42
Return on Equity (ROE)
10.79%-33.22%-4.57%97.53%-
Return on Assets (ROA)
-17.17%-20.02%-3.30%65.28%-
Return on Capital Employed (ROCE)
-31.20%-33.70%-6.80%62.60%-353.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
1.44%-1.65%---
FCF Yield
-4.10%-1.44%---
Buyback Yield / Dilution
-9.54%-53.73%10.08%-227.30%-